Prime Capital Investment Advisors, LLC Novo Nordisk A S Transaction History

Prime Capital Investment Advisors, LLC

$7.73 Billion
Q3 2025

A detailed history of Prime Capital Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 58,601 shares of NVO stock, worth $2.84 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

58,601

Previous 73,219 19.96%

Holding current value

$2.84 Million

Previous $5.05 Million 35.66%

% of portfolio

0.04%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$45.38 - $71.7 $663,364 - $1.05 Million	-14,618 Reduced 19.96%	58,601 $3.25 Million
Q2 2025 Jul 22, 2025	BUY	$58.08 - $81.05 $464,523 - $648,237	7,998 Added 12.26%	73,219 $5.05 Million
Q1 2025 May 13, 2025	BUY	$69.3 - $90.95 $180,803 - $237,288	2,609 Added 4.17%	65,221 $4.53 Million
Q4 2024 Feb 12, 2025	SELL	$85.0 - $120.04 $134,215 - $189,543	-1,579 Reduced 2.46%	62,612 $5.39 Million
Q3 2024 Nov 05, 2024	SELL	$119.07 - $145.42 $1.13 Million - $1.38 Million	-9,497 Reduced 12.89%	64,191 $7.64 Million

Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $1.4 Million - $1.68 Million	-11,423 Reduced 13.42%	73,688 $10.5 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $2.4 Million - $3.2 Million	-23,515 Reduced 21.65%	85,111 $10.9 Million
Q4 2023 Jan 24, 2024	BUY	$87.78 - $105.45 $8.19 Million - $9.84 Million	93,307 Added 609.09%	108,626 $11.2 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $660,770 - $1.45 Million	7,266 Added 90.23%	15,319 $1.39 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $616,276 - $682,140	3,951 Added 96.32%	8,053 $1.3 Million
Q1 2023 May 05, 2023	SELL	$132.34 - $159.14 $8,999 - $10,821	-68 Reduced 1.63%	4,102 $652,000
Q4 2022 Feb 08, 2023	BUY	$102.55 - $135.33 $119,470 - $157,659	1,165 Added 38.77%	4,170 $564,000
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $5,145 - $6,314	54 Added 1.83%	3,005 $299,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $13,214 - $15,591	-128 Reduced 4.16%	2,951 $329,000
Q4 2021 Feb 07, 2022	BUY	$95.88 - $117.08 $12,272 - $14,986	128 Added 4.34%	3,079 $345,000
Q3 2021 Nov 09, 2021	SELL	$84.42 - $106.62 $42,294 - $53,416	-501 Reduced 14.51%	2,951 $283,000
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $4,736 - $5,933	-70 Reduced 1.99%	3,452 $289,000
Q1 2021 May 07, 2021	BUY	$67.06 - $75.82 $193,803 - $219,119	2,890 Added 457.28%	3,522 $237,000
Q4 2020 Feb 03, 2021	SELL	$63.89 - $73.8 $894 - $1,033	-14 Reduced 2.17%	632 $44,000
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $3,311 - $3,651	-52 Reduced 7.45%	646 $45,000
Q2 2020 Jul 17, 2020	BUY	$58.54 - $67.94 $14,635 - $16,985	250 Added 55.8%	698 $46,000
Q1 2020 May 04, 2020	SELL	$49.46 - $64.78 $1,928 - $2,526	-39 Reduced 8.01%	448 $27,000
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $2,592 - $3,029	-52 Reduced 9.65%	487 $28,000
Q3 2019 Nov 05, 2019	BUY	$47.54 - $53.43 $25,624 - $28,798	539 New	539 $28,000

Others Institutions Holding NVO

# of Institutions

1,694

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.

Account

Prime Capital Investment Advisors, LLC Novo Nordisk A S Transaction History